Artirat Charukitpipat, CEO of Bumrungrad International Hospital, along with Associate Professor Dr. Taveesin Tanprayoon, Chief Medical Officer, and Professor Dr. Koonlawee Nademanee, Director of the Bumrungrad Heart Institute in Thailand, have spearheaded the establishment of a world-class heart institute. This institute is dedicated to pioneering research, innovation, and the development of clinically effective techniques for addressing various heart conditions.
The institute specializes in the treatment of coronary artery diseases, arrhythmia, advanced heart failure and heart transplantation, structural heart disease, cardiogenetics, and congenital heart disease. Additionally, it offers comprehensive cardiac screening and preventive care. The Bumrungrad Heart Institute has successfully achieved its objectives, delivering truly exceptional care and consistently striving to uphold the highest levels of patient satisfaction.
Professor Dr. Koonlawee Nademanee emphasized the institute's commitment to becoming a cutting-edge medical facility in all facets of cardiology, encompassing coronary artery disease, arrhythmia, advanced heart failure and heart transplantation, structural heart disease, cardiogenetics, congenital heart disease, cardiac screening, and preventive care. Furthermore, the institute is equipped with a state-of-the-art cardiac care unit that provides round-the-clock support for cardiac patients in need of acute care or postoperative recovery, facilitating their prompt return to optimal health.
Read more and share the research work at https://www.heart.scientexconference.com/
